Notably, the addition of ruxolitinib, a small molecule inhibitor of JAK1/JAK2, to block the IL-6/JAK/STAT3 signaling pathway resulted in a significant decrease in the levels of these cytokines in ...

A new study published in the International Journal of Molecular Sciences finds that topical application of cannabigerol (CBG) ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

The agency approved delgocitinib cream 2% (Anzupgo) for adults with moderate-to-severe CHE, according to a statement from LEO Pharma. Approval of the multitargeted JAK-STAT pathway inhibitor ...

Shi’s study, "Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling," was recently published in Nature Communications. “Concerted efforts ...